Cytomegalovirus (CMV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cytomegalovirus (CMV) Tests Market Report Overview
The Cytomegalovirus (CMV) tests market size was valued at $47.2 million in 2023. Cytomegalovirus (CMV) is a widely distributed pathogen that causes congenital infection worldwide. It is a human herpesvirus that can be transmitted through intimate contact with infected bodily fluids and through transplacental transfer, blood transfusion, or organ transplantation. CMV infections are most prevalent in pregnant women, immunocompromised patients, and infants.
CMV Tests Market Outlook 2023-2033 ($ Million)
Buy the Full Report for More Insights on the CMV tests Market Forecast, Download a Free Sample Report
The CMV tests market research report explains the market behavior, which will help identify quantitative market trends within in vitro diagnostics therapeutic areas. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies. The CMV tests market model also discusses the detailed impact of COVID-19 on the CMV tests market for 2020 and beyond.
Market Size (2023) | $47.2 million |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
CMV Tests Market Dynamics
CMV represents the most common congenital, viral infection in the developed world, and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general, testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. The market is driven by several factors such as increases in the number of immunocompromised cases and sperm donations. The sales of these devices are also impacted by fluctuations in live birth rates, which heavily influence diagnostic and screening tests performed for both pregnant women and neonates. Additionally, there are multiple ongoing clinical studies aimed at discovering potential vaccines for CMV, as well as antiviral medicines to reduce transmission. These have the potential to strongly impact the CMV tests market.
Buy the Full Report for Additional CMV Tests Market Dynamics, Download a Free Sample Report
CMV Tests Market Segments
The key segments in the CMV tests market are Cytomegalovirus (CMV) Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests, Cytomegalovirus (CMV) Nucleic Acid Amplification Tests (NAATs), and Other Cytomegalovirus (CMV) Tests. In 2023, the Cytomegalovirus (CMV) Nucleic Acid Amplification Tests (NAATs) segment dominated the CMV tests market share.
CMV Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights into the CMV Tests Market Segments, Download a Free Sample Report
CMV Tests Market Segmentation by Regions
The key regions in the CMV tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America was the leading regional market. However, the CMV tests market is expected to decline in North America during the forecast years as countries try to recover from the drastic drop in CMV sales due to COVID-19. The need for CMV tests for symptomatic or asymptomatic infants will decline. Additionally, with the development of prenatal screening and diagnostic technologies, fewer children will be born with CMV.
CMV Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights in the CMV Tests Market, Download A Free Sample Report
CMV Tests Market – Competitive Landscape
The key companies in the CMV tests market are Roche Diagnostics International Ltd, Luminex Corp, Abbott Laboratories, Qiagen NV, and Beckman Coulter Inc. among others. In 2023, Roche Diagnostics International Ltd accounted for the highest CMV tests market share and value.
CMV Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the CMV Tests Market, Download a Free Sample Report
Segments Covered in this Report
CMV Tests Segment Outlook ($ Million, 2015-2033)
- Cytomegalovirus (CMV) Enzyme Immuno Assay/Enzyme-Linked Immunosorbent Assay (EIA/ELISA) Tests
- Cytomegalovirus (CMV) Nucleic Acid Amplification Tests (NAATs)
- Other Cytomegalovirus (CMV) Tests
CMV Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are –
Currently marketed CMV tests market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total CMV tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the CMV tests market.
- Competitive dynamics insights and trends provided for the CMV tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, American Master Tech Scientific Inc, Danaher Corp, MBL International Corporation, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin SpA, Erba Diagnostics Mannheim GmbH, Immucor Inc, E. Merck KGaA, Qiagen NV, Quidelortho Corp, Altona Diagnostic GmbH, F. Hoffmann-La Roche Ltd, Siemens AG, Trinity Biotech Plc., and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
- CMO executives who must have a deep understanding of the CMV tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on CMV tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving CMV tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the CMV tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific CMV tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
American Master Tech Scientific Inc
Danaher Corp
bioMerieux SA
MBL International Corporation
Bio-Rad Laboratories Inc
DiaSorin SpA
Erba Diagnostics Mannheim GmbH
Immucor Inc
Merck KGaA
Qiagen NV
Quidelortho Corp
Altona Diagnostic GmbH
F. Hoffmann-La Roche Ltd
Siemens AG
Trinity Biotech Plc.
Others
Frequently asked questions
-
What was the CMV test market size in 2023?
The CMV test market size was $47.2 million in 2023.
-
Which was the leading segment in the CMV tests market in 2023?
In 2023, the Cytomegalovirus (CMV) Nucleic Acid Amplification Tests (NAATs) segment dominated the CMV tests market share.
-
Which region held the largest share of the CMV tests market in 2023?
North America was the largest regional market for CMV tests in 2023.
-
Which are the leading players in the CMV tests market?
The key companies in the CMV tests market are Abbott Laboratories, American Master Tech Scientific Inc., Danaher Corp, MBL International Corporation, bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin SpA, Erba Diagnostics Mannheim GmbH, Immucor Inc., E. Merck KGaA, Qiagen NV, Quidelortho Corp, Altona Diagnostic GmbH, F. Hoffmann-La Roche Ltd, Siemens AG, Trinity Biotech Plc., and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.